Drug discontinuation effects are part of the pharmacology of a drug
- PMID: 21849624
- PMCID: PMC3200000
- DOI: 10.1124/jpet.111.183285
Drug discontinuation effects are part of the pharmacology of a drug
Abstract
Most reviews of drug withdrawal effects focus on drugs of potential abuse such as opioids, benzodiazepines, etc. Abrupt discontinuation of many other drugs used in medicine cause withdrawal syndromes, some of which can be fatal. Discontinuation of a number of cardiovascular drugs can increase risk of cardiovascular events above that of people not taking these drugs. These include β-adrenergic receptor antagonists, aspirin, HMG-CoA reductase inhibitors (statins), and heparin. Rebound hypertension occurs after abrupt cessation of many antihypertensive drugs. The possibility of discontinuation syndromes has usually been neglected until adverse clinical events force them to be noticed. Attention to the possibility of drug discontinuation effects is an important part of drug safety evaluation.
Similar articles
-
Abrupt discontinuation of antihypertensive therapy.South Med J. 1981 Sep;74(9):1112-23. doi: 10.1097/00007611-198109000-00026. South Med J. 1981. PMID: 6116286
-
Cardiovascular therapeutics.Br J Hosp Med (Lond). 2008 Sep;69(9):M136-40. doi: 10.12968/hmed.2008.69.Sup9.31061. Br J Hosp Med (Lond). 2008. PMID: 18819300 No abstract available.
-
Aspirin discontinuation syndromes: clinical implications of basic research studies.Am J Cardiovasc Drugs. 2013 Dec;13(6):377-84. doi: 10.1007/s40256-013-0044-1. Am J Cardiovasc Drugs. 2013. PMID: 24045958
-
Antihypertensive drug withdrawal syndrome.Drug Intell Clin Pharm. 1982 Nov;16(11):817-22. doi: 10.1177/106002808201601102. Drug Intell Clin Pharm. 1982. PMID: 6129120 Review.
-
Novel mechanistic and clinical implications concerning the safety of statin discontinuation.Pharmacol Rep. 2011;63(4):867-79. doi: 10.1016/s1734-1140(11)70602-8. Pharmacol Rep. 2011. PMID: 22001974 Review.
Cited by
-
Gradually tapering off antipsychotics: lessons for practice from case studies and neurobiological principles.Curr Opin Psychiatry. 2024 Jul 1;37(4):320-330. doi: 10.1097/YCO.0000000000000940. Epub 2024 May 9. Curr Opin Psychiatry. 2024. PMID: 38726815 Free PMC article. Review.
-
Clozapine withdrawal catatonia: A case report.Indian J Psychiatry. 2023 Jul;65(7):797-798. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_191_23. Epub 2023 Jul 12. Indian J Psychiatry. 2023. PMID: 37645360 Free PMC article. No abstract available.
-
Priorities for future research on reducing and stopping psychiatric medicines using a James Lind Alliance priority setting partnership: The PROTECT study protocol.HRB Open Res. 2022 Nov 10;5:72. doi: 10.12688/hrbopenres.13649.1. eCollection 2022. HRB Open Res. 2022. PMID: 37636245 Free PMC article.
-
High levels of benzodiazepines after treatment of moderate alcohol withdrawal syndrome: the problem of incomplete detoxification.Postep Psychiatr Neurol. 2022 Mar;31(1):1-5. doi: 10.5114/ppn.2022.114662. Epub 2022 Mar 22. Postep Psychiatr Neurol. 2022. PMID: 37082417 Free PMC article.
-
Estimating Risk of Antidepressant Withdrawal from a Review of Published Data.CNS Drugs. 2023 Feb;37(2):143-157. doi: 10.1007/s40263-022-00960-y. Epub 2022 Dec 14. CNS Drugs. 2023. PMID: 36513909 Free PMC article. Review.
References
-
- Alderman EL, Coltart DJ, Wettach GE, Harrison DC. (1974) Coronary artery syndromes after sudden propranolol withdrawal. Ann Int Med 81:625–627 - PubMed
-
- Bijsterveld NR, Moons AH, Meijers JC, Tijssen JG, Büller HR, Levi M, Peters RJ. (2002) Rebound thrombin generation after heparin therapy in unstable angina. A randomized comparison between unfractionated and low-molecular-weight heparin. J Am Coll Cardiol 39:811–817 - PubMed
-
- Bijsterveld NR, Peters RJ, Murphy SA, Bernink PJ, Tijssen JG, Cohen M. (2003) Recurrent cardiac ischemic events early after discontinuation of short-term heparin treatment in acute coronary syndromes: results from the Thrombolysis in Myocardial Infarction (TIMI) 11B and Efficacy and Safety of Subcutaneous Enoxaparin in Non-Q-Wave Coronary Events (ESSENCE) studies. J Am Coll Cardiol 42:2083–2089 - PubMed
-
- Blanco M, Nombela F, Castellanos M, Rodriguez-Yáñez M, García-Gil M, Leira R, Lizasoain I, Serena J, Vivancos J, Moro MA, et al. (2007) Statin treatment withdrawal in ischemic stroke: a controlled randomized study. Neurology 69:904–910 - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical